SECONDARY PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC DISEASES OF CONNECTIVE TISSUE

SECONDARY PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC DISEASES OF CONNECTIVE TISSUE

Show other versions (1)

<p>Modern definition of pulmonary arterial hypertension (PAH) as well as data on prevalence and incidence of secondary PAH in systemic disease of connective tissue is presented, including data of USA, France and Scotland registers. The main chains of pathogenesis, classification approaches, c...

Full description

Bibliographic Details
Main Authors:	N. A. Shostak, J. K. Novikov, A. L. Chernayev, A. A. Klimenko, P. V. Novikov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	вторичная легочная артериальная гипертензия системные заболевания соединительной ткани системная склеродермия фактор Фон Виллебранда
Online Access:	http://www.rpcardio.ru/jour/article/view/635

Similar Items

PULMONAR.Y ARTERIAL HYPERTENSION ASSOCIATED WITH A SYSTEMIC SCLEROSIS: REVIEW OF LITERATURE
by: N. N. Yudkina, et al.
Published: (2015-12-01)

The state of the digestive system in children with systemic connective tissue diseases
by: I. D. Chyzhevskaya, et al.
Published: (2020-03-01)

THE ROLE OF RIOCIGUAT IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONNECTIVE TISSUE DISEASE
by: O. Ya. Vasiltseva, et al.
Published: (2019-12-01)

DEFENSE MECHANISMS OF CONNECTIVE TISSUE DISEASES PATIENTS
by: Tuyaara Nikiforovna Sidorova, et al.
Published: (2018-10-01)

Positivity for antiribonucleoprotein antibodies in rheumatic diseases: focus on scleroderma systematica
by: R. U. Shayakhmetova, et al.
Published: (2018-01-01)

A clinical case of secondary hypertension in a young woman with coarctation of the aorta
by: M. A. Manukyan, et al.
Published: (2022-01-01)

ARTERIAL HYPERTENSION IN SYSTEMIC VASCULITIS: CLINICAL FEATURES AND PRINCIPLES OF PATHOGENETIC THERAPY. PART I. CLINICAL, DIAGNOSTIC AND PATHOGENETIC ASPECTS
by: E. A. Praskurnichy, et al.
Published: (2015-09-01)

ARTERIAL HYPERTENSION IN SYSTEMIC VASCULITIS: CLINICAL FEATURES AND PRINCIPLES OF PATHOGENETIC THERAPY. PART II. POSSIBILITIES OF OPTIMIZING OF ANTIHYPERTENSIVE TREATMENT
by: E. A. Praskurnichy, et al.
Published: (2015-09-01)

Informative value of procalcitonin in determining the nature of an inflammatory response in rheumatology
by: O. V. Teplyakova, et al.
Published: (2017-03-01)

Risk factors associated with the development of undifferentiated connective tissue dysplasia
by: G. Yu. Kalaeva, et al.
Published: (2018-07-01)

CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2019-12-01)

CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
by: E. A. Devetyarova, et al.
Published: (2018-06-01)

Pulmonary Involvement at Connective Tissue Systemic Diseases in Children
by: Maria I. Kaleda, et al.
Published: (2021-05-01)

RESPIRATORY FUNCTION IN PATIENTS WITH RHEUMATIC HEART DISEASE COMPLICATED WITH PULMONARY HYPERTENSION
by: N. A. Shostak, et al.
Published: (2016-01-01)

Comparison of endothelial function in patients with Stage I-II arterial hypertension and stable angina, receiving various bradycardic agents and perindopril
by: L. L. Kirichenko, et al.
Published: (1970-01-01)

Experimental models of dermatological diseases
by: O. N. Sergeeva, et al.
Published: (2019-10-01)

EFFICACY AND SAFETY OF FIXED COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE FOR MANAGEMENT OF VASCULAR DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION
by: L. A. Haisheva
Published: (2016-01-01)

Drug-induced pulmonary artery hypertension
by: O. D. Ostroumova, et al.
Published: (2022-05-01)

CARDIOPULMONARY EXCERSISE TESTING IN RISK STRATIFICATION IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: I. N. Taran, et al.
Published: (2017-12-01)

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease
by: A. A. Shmalts, et al.
Published: (2022-10-01)

Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report
by: E. A. Rezukhina, et al.
Published: (2021-09-01)

IMPORTANCE OF CYCLOPHOSPHANUM IN THE TREATMENT OF INTERSTITIAL LUNG LESION IN PATIENTS WITH SCLERODERMA SYSTEMATICA (A REVIEW OF LITERATURE)
by: Olga Aleksandrova Koneva
Published: (2010-06-01)

ORAL ANTICOAGULANTS IN PATIENTS WITH DIFFERENT FORMS OF PULMONARY ARTERIAL HYPERTENSION, ASPECTS OF THE PROBLEM
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01)

CLINICAL FEATURES OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL SYSTEMIC-TO-PULMONARYSHUNTS
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01)

EXPERIENCE OF IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION PATIENTS MANAGEMENT IN URAL FEDERAL DISTRICT: FEATURES OFOUTPATIENT-HOSPITAL INTERACTIONS
by: S. V. Shalaev, et al.
Published: (2019-03-01)

OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY
by: V. V. Gramovich, et al.
Published: (2018-12-01)

Severe lung involvement in a female patient with undiagnosed systemic lupus erythematosus
by: T. N. Gavva, et al.
Published: (2018-12-01)

Formation of the pulmonary hypertension in patients with a liver cirrhosis
by: T. P. Kalachyova, et al.
Published: (2009-08-01)

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION AND PROBLEMS OF RARE AND INTERDISCIPLINARY DISEASE
by: N. A. Shostak, et al.
Published: (2015-09-01)

COMPARATIVE CLINICAL CHARACTERISTICS OF PATIENTS WITH VARIOUS FORMS OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE, ACCORDING TO THE CLINICAL CLASSIFICATION
by: S. E. Gratsianskaya, et al.
Published: (2019-12-01)

Diagnosis of pulmonary hypertension associated with congenital heart disease. Part 1. Definition, classification and initial examination of patients
by: S. V. Gorbachevsky, et al.
Published: (2021-12-01)

Contemporary treatment of pulmonary arterial hypertension: the North-West Registry data analysis
by: N. S. Goncharova, et al.
Published: (2012-08-01)

Ways to improve the diagnosis and treatment of interstitial lung disease associated with systemic sclerosis in the Siberian Federal District (materials of the advisory board of rheumatologists and pulmonologists from December 08, 2019)
by: L. I. Alekseeva, et al.
Published: (2020-10-01)

Connective Tissue Growth Factor in Normal and Pathological Processes
by: S. V. Topolyanskaya
Published: (2020-07-01)

Corrected orthogonal vectorcardiography in pulmonary hypertension diagnostics
by: E. S. Yurasova, et al.
Published: (2005-12-01)

LEFT MAIN CORONARY ARTERY COMPRESSION SYNDROME IN PATIENT WITH PULMONARY ARTERIAL HYPERTENSION. FIRST CLINICAL EXPERIENCE
by: A. N. Bykov, et al.
Published: (2018-12-01)

Bone mineral density in patients with systemic scleroderma
by: O. V. Dobrovolskaya, et al.
Published: (2019-03-01)

COVID-19 pandemic challenges: on the way to overcome obstacles in realization of PAH-specific therapy treatment goals
by: E. A. Rezukhina, et al.
Published: (2021-11-01)

Predictors of using extracorporeal membrane oxygenation in lung transplantation
by: M. Sh. Khubutiya, et al.
Published: (2019-06-01)

EXPERIENCE OF USING THE NONSELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
by: M. A. Simakova, et al.
Published: (2018-04-01)